As a caregiver, you play an important role in your family member’s or friend’s health. But it is also important to manage your own health and wellness. Below are some tips for taking care of yourself:
Take time for yourself
Try to set aside time each day doing something for yourself. This could be a short walk, a trip to run errands, or watching your favorite TV show.
Keep up with routines
If possible, try to stick with some of your regular activities. This can help reduce stress you may be feeling. If you love going to yoga, try to go at least once a week. It may not be as frequent or as long as you’d like, but it can be something you look forward to.
Pay attention to your physical health
Sometimes you may be so busy taking care of your loved one that you forget about your own personal health. Be sure to schedule regular appointments and checkups with your doctor and find some time to exercise.
Ask others for help
Just because you are a caregiver doesn’t mean you have to do it alone. Remember that you may need support too. Ask friends and family members to help out with tasks when you need help. Working together can help you make supporting the person you are caring for more manageable.
Join a support group
A support group can help you connect with people who understand what you’re going through. They also can provide encouragement and ideas that might help you.
While it is important to manage your own personal care, below are a few tips to help support your family member or friend throughout treatment.
Prepare for appointments
Before each appointment, make a list of questions that you or the person you are caring for may have. Also be sure to bring a notebook to take notes during each visit.
Keep a folder with all important papers, test results, phone numbers, and insurance documents. This will make it easier to find everything you may need at any moment.
Help keep track of treatment
The person you are caring for may not be able to keep track of how he or she is feeling throughout treatment. You can help by keeping a diary that includes any side effects that may occur and changes in appetite or mood.
If you’re getting IMFINZI, Lighthouse is here to help support you as you manage your life with cancer.
What is the most important information I should know about IMFINZI?
IMFINZI is a medicine that may treat a type of cancer in the bladder and urinary tract by working with your immune system.
In some patients, IMFINZI can cause the immune system to attack normal organs and tissues and can affect the way they work. These problems can sometimes become serious or life-threatening and can lead to death.
Call or see your healthcare provider right away if you develop any symptoms of the following problems or if these symptoms get worse:
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with IMFINZI. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may delay or completely stop treatment with IMFINZI if you have severe side effects.
Before you receive IMFINZI, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take. This includes prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of IMFINZI?
IMFINZI can cause serious side effects (see above).
The most common side effects include:
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of IMFINZI. Ask your healthcare provider or pharmacist for more information.
IMFINZI™ (durvalumab) is a prescription medicine used to treat a type of cancer in the bladder and urinary tract called urothelial carcinoma.
IMFINZI may be used when:
It is not known if IMFINZI is safe and effective in children.
IMFINZI was FDA approved based on a clinical study that measured how many patients responded and how long they responded. The study is ongoing to confirm clinical benefit.